523 results for "krytan tek side effects"

Search for:

Date Range to

523 Results on GlaucomaToday.com

December 2014December 2014

The Literature By Dipika B. Joshi, MD, and Tak Yee Tania Tai, MD

Neuroprotection in Glaucoma Researchers continue to seek strategies and agents independent of IOP lowering that will protect neurons from apoptosis.
By Zakaria Bannur, MD, MSc(MEDICINE); Sushil Vasudevan, MBBS, MSurg(Ophth); Jonathan G. Crowston, FRCOphth, FRANZCO, PhD; and Ivan Goldberg, AM, MBBS, FRANZCO, FRACS

Micropulse Laser Trabeculoplasty After Previous Laser Trabeculoplasty By Tak Yee Tania Tai, MD

Will the Cost of Clinical Trials Quash Change in Glaucoma Treatment? Financial burden compromises phase 3 trials and prolongs the approval of surgical devices.
By Alan L. Robin, MD

Topical Glaucoma Treatment and the Cornea Alternative strategies may benefit patients with a compromised ocular surface.
By Adam C. Reynolds, MD

Vascular Considerations in Glaucoma Management Evidence strongly suggests that ocular blood flow plays a role in glaucoma pathophysiology.
By Alon Harris, MS, PhD; Rehan Hussain, MD; Scott Wentz; and Brent Siesky, PhD

Genetics in Glaucoma Diagnosis and Management Gene-based tests and therapies carry important implications for clinical practice.
By Inas F. Aboobakar, BS, and R. Rand Allingham, MD

Immunologic Considerations in Glaucoma Care Innate and adaptive immune responses represent elusive but important components of the human glaucomatous process.
By Louis R. Pasquale, MD, and Meredith Gregory-ksander, PhD

Managing Systemic Disease in the Glaucoma Patient Many systemic diseases may be correlated with glaucoma. Conversely, glaucoma treatments can affect a patient’s other systemic diseases.
By Jennifer Somers Weizer, MD

Current Approaches to Low-Tension Glaucoma This challenging condition requires individualized care.
By Carla J. Siegfried, MD

Negotiating Language Barriers Practitioners describe how they build trust through communication with patients who do not speak English.
By Rohit Varma, MD, MPH; Justin Schweitzer, OD; Darrell Wudunn, MD, PhD; and Walter O. Whitley, OD, MBA

Tube Coverage: Another Approach By Jonathan S. Myers, MD

Industry News and Innovations

October 2014October 2014

Changing Paradigms in Glaucoma Care By Steven D. Vold, MD

Shan Lin, MD

The Role of 24-Hour IOP Monitoring in Glaucoma Continuous monitoring would allow clinicians to develop a more complete IOP profile on which to base long-term treatment goals for patients.
By Leonard K. Seibold, MD; Kaweh Mansouri, MD, MPH; Jeffrey R. SooHoo, MD; and Malik Y. Kahook, MD

The Future of Noninvasive Surgeries to Enhance Aqueous Outflow Sonic energy and the modified delivery of laser energy appear to be the next wave.
By Jeffrey A. Kammer, MD

Sidebar: Micropulse Laser Trabeculoplasty By Iqbal Ike K. Ahmed, MD, FRCSC

Sidebar: Pattern Scanning Laser Trabeculoplasty By Miho Nozaki, MD, PhD

The Jigsaw Effect Refined perimetric analysis confirms that the brain coordinates bilateral glaucomatous neurodegeneration to optimize the surviving binocular visual field.
By William Eric Sponsel, MD

The Effects of Changing Demographics on Ophthalmology An increase in life expectancy means more need for eye care as the population ages.
By Norbert Pfeiffer, MD, PhD

Does Blood Flow Measurement Have a Role in Glaucoma Care? Advanced imaging technologies and therapeutic options make blood flow measurement a prime consideration in glaucoma monitoring.
By Ahmad A. Aref, MD; Yali Jia, PhD; and David Huang, MD, PhD

Implanting a Valved Tube Shunt By Soosan Jacob, MS, FRCS, DNB

Industry News and Innovations

Ruminations for the Voting Booth Ophthalmologists need to research candidates running for office before voting in the 2014 midterm elections.
By Jeffrey J. Kimbell and Kenneth L. Hodge

August 2014August 2014

The Literature By Sunju Park, MD, and Assumpta Madu, MD, PharmD, MBA

Arthur J. Sit, SM, MD By Arthur J. Sit, SM, MD

Could Glaucoma Be a Two-Pressure Disease? Research on the effects of space flight on the ocular system may help reveal if cerebrospinal fluid pressure plays a role in the development of glaucoma and idiopathic intracranial hypertension.
By John P. Berdahl, MD

The Societal Costs of Blindness From Uncontrolled Glaucoma By Yvonne N. Covin, MD; Daniel Laroche, MD; and Mildred M. G. Olivier, MD

Advances in 24-Hour IOP Monitoring This technology will lead to more personalized care for patients.
By Robert Chang, MD

Diurnal IOP Control: How Important Is It? Many glaucoma experts agree that IOP variation is important to evaluating and managing patients with glaucoma.
By Sanjay Asrani, MD

Enhancing Glaucoma Patients’ Adherence to Prescribed Medical Therapy Tools to meet the challenge.
By Gail F. Schwartz, MD

New Horizons in Glaucoma Drug Delivery Many products are in research and development, but there are numerous challenges.
By Gary D. Novack, PhD

Current Concepts in Laser Trabeculoplasty Advances in technology make this option an attractive alternative or adjunct to medical therapy.
By Jason Bacharach, MD

Filtration Surgery: Indications and Improvements The future of this intervention likely depends on the development of devices that communicate between the anterior chamber and the episcleral space.
By Michael Stiles, MD

The Evolving Indications for Microinvasive Glaucoma Surgery Less surgery may be more.
By Robert Marquis, MD, PhD

Novel Risk Factors for Glaucoma Research suggests that many issues other than IOP may play a role in the pathophysiology of glaucoma.
By Shan Lin, MD

June 2014June 2014

The Literature By Joseph Panarelli, MD, and Lauren Blieden, MD

The Optometrist’s Role in Glaucoma Care Involvement varies among providers for several reasons.
By Murray Fingeret, OD

Does the Integrated MD-OD Model Represent the Future? Greater collaboration between these eye care specialists will have a growing role in the management of glaucoma patients.
By Anup K. Khatana, MD

1234567891011121314 | Next >